Physician profile
Gary Locke
NPI 1346361342
$762.74
in general payments reported to CMS, 2019-2025
10 companies · $78.15 in 2025
The $78.15 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $16.15 · 2022: $52.68 · 2023: $70.66 · 2024: $182 · 2025: $78.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177 · Gift: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.35 |
| Gift | $153.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $305.96 | 2019 | |
| A-Dec, INC. | $153.05 | 2024 | |
| Peter Brasseler Holdings, LLC | $57.26 | 2019-2020 | |
| Solventum Corporation | $56.42 | 2025 | 3m Clinpro, Filtek |
| Kerr Corporation | $52.68 | 2022 | |
| Kulzer, LLC | $38.38 | 2023-2025 | |
| Dentsply Sirona INC | $34.95 | 2019-2023 | Midwest Stylus Plus |
| Voco America INC. | $28.54 | 2024 | Grandio So Heavy Flow, Meron Plus Qm, Grandio So |
| 3m Company | $22.17 | 2023 | Scotchbond Universal Plus, 3m Filtek, Relyx Unicem Aplicap |
| Colgate Oral Pharmaceuticals, INC. | $13.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Locke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.